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Members of the EGF-CFC family play essential roles in embryonic development and have been implicated in
tumorigenesis. The TGFb signals Nodal and Vg1/GDF1, but not Activin, require EGF-CFC coreceptors to activate Activin
receptors. We report that the TGFb signaling antagonist Lefty also acts through an EGF-CFC-dependent mechanism.
Lefty inhibits Nodal and Vg1 signaling, but not Activin signaling. Lefty genetically interacts with EGF-CFC proteins and
competes with Nodal for binding to these coreceptors. Chimeras between Activin and Nodal or Vg1 identify a 14 amino
acid region that confers independence from EGF-CFC coreceptors and resistance to Lefty. These results indicate that
coreceptors are targets for both TGFb agonists and antagonists and suggest that subtle sequence variations in TGFb
signals result in greater ligand diversity.
Introduction
The analysis of whole-genome sequences has revealed that
most signaling systems consist of multiple ligands that
converge on a relatively small set of receptors and pathway-
speciﬁc transcription factors. In the case of human trans-
forming growth factor-b (TGFb) signaling, 42 TGFbs converge
on seven type I receptors, ﬁve type II receptors, and two
classes of Smad signal transducers (reviewed in Shi and
Massague 2003). This convergence has raised the question of
how ligand diversity and signaling speciﬁcity among different
signals can be achieved. If different TGFbs activate the same
receptors, it is unclear how these ligands can vary in their
function (diversity) or how a given signal can have a unique
role (speciﬁcity). Biochemical studies have suggested that
ligand diversity can be attained by differential stability and
receptor afﬁnity, leading to differences in signaling strength
(reviewed in Piek et al. 1999; Shi and Massague 2003). An
additional source of ligand variability stems from differential
ligand movement through a ﬁeld of cells, rendering related
signals either short- or long-range (Chen and Schier 2001).
Finally, speciﬁcity and diversity can also be determined by
ligand-speciﬁc cofactors or inhibitors (Piek et al. 1999; Shi
and Massague 2003). A prominent example involves epider-
mal growth factor–Cripto/FRL-1/Cryptic (EGF-CFC) corecep-
tors and the TGFbs Activin, Nodal, and Vg1/GDF1 (growth
and differentiation factor-1). In this case, differential depend-
ence on a coreceptor leads to ligand diversity and signaling
speciﬁcity (reviewed in Schier 2003).
Members of the Nodal, Activin, and Vg1/GDF1 subfamilies
display similar activities and are potent mesendoderm
inducers in vertebrates (reviewed in Schier and Shen 2000).
Genetic and biochemical studies have shown that EGF-CFC
proteins are essential for signaling by Nodal and Vg1/GDF1
(Gritsman et al. 1999; Reissmann et al. 2001; Yeo and
Whitman 2001; Bianco et al. 2002; Sakuma et al. 2002; Yan
et al. 2002; Cheng et al. 2003). EGF-CFC proteins are
extracellular glycosylphosphatidylinositol (GPI)-linked fac-
tors and include One-eyed pinhead (Oep) in zebraﬁsh and
mammalian Cripto and Cryptic (reviewed in Shen and Schier
2000; Minchiotti et al. 2002; Schier 2003). Genetic studies in
zebraﬁsh and mouse have shown that EGF-CFC proteins and
Nodal are required for mesoderm and endoderm induction
(Conlon et al. 1991, 1994; Zhou et al. 1993; Ding et al. 1998;
Feldman et al. 1998; Gritsman et al. 1999). For example,
zebraﬁsh embryos lacking both the maternal and zygotic
contribution of Oep (MZoep) lack all endoderm and most
mesoderm, similar to the double mutants for the zebraﬁsh
Nodal-related genes cyclops and squint (sqt) (Feldman et al.
1998; Gritsman et al. 1999). Moreover, Nodal and Vg1/GDF1
are inactive in MZoep mutants (Gritsman et al. 1999; Cheng et
al. 2003). During later stages of development, Oep, Cryptic,
Nodal, and GDF1 are required for proper left–right axis
formation (Gaio et al. 1999; Yan et al. 1999; Bamford et al.
2000; Rankin et al. 2000; Brennan et al. 2002; Long et al.
2003).
The EGF-CFC protein Cripto is highly overexpressed in
human epithelial cancers, such as breast and colon carcino-
mas (reviewed in Salomon et al. 2000), and has been
implicated in tumorigenesis (Ciardiello et al. 1991, 1994;
Baldassarre et al. 1996; De Luca et al. 2000; Salomon et al.
2000; Adkins et al. 2003). The mechanism by which Cripto
mediates tumorigenesis is not well understood. Several
possibilities include mediating Nodal/GDF1 signaling (Grits-
man et al. 1999; Reissmann et al. 2001; Yeo and Whitman
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Cheng et al. 2003), antagonizing Activin signaling (Adkins et
al. 2003; Gray et al. 2003), or activating Akt and mitogen-
activated protein kinase (MAPK) pathways independently of
the TGFb signals and Activin receptors (Ebert et al. 1999;
Bianco et al. 2002, 2003). Whatever the molecular mechanism
of Cripto activity, inhibition of Cripto by antisense or
antibody blockade can inhibit tumor cell proliferation in
vitro and in vivo (Ciardiello et al. 1994; Baldassarre et al.
1996; De Luca et al. 2000; Adkins et al. 2003).
Biochemically, EGF-CFC proteins can act as coreceptors
for Nodal and Vg1/GDF1 to bind and activate the type I
Activin receptor Alk4 and the type II Activin receptor
ActRIIB (Reissmann et al. 2001; Yeo and Whitman 2001;
Sakuma et al. 2002; Yan et al. 2002; Bianco et al. 2002; Cheng
et al. 2003). In the absence of EGF-CFC proteins, these TGFbs
cannot form a complex with Activin receptors. Strikingly,
Activin utilizes the same receptors as Nodal and Vg1/GDF1,
but does not require EGF-CFC coreceptors (Mathews and
Vale 1991; Attisano et al. 1992, 1996; Hemmati-Brivanlou and
Melton 1992; Mathews et al. 1992; ten Dijke et al. 1994; Chang
et al. 1997). For instance, Activin can signal in MZoep mutants
(Gritsman et al. 1999). This ligand diversity between Activin
and Nodal or Vg1/GDF1 raises the question of which
sequences confer coreceptor dependence or independence.
Activin, Nodal, and Vg1/GDF1 are highly related and are
thought to acquire very similar folds. Like other TGFb
ligands, Activin has four major structural features: a b-
stranded Finger 1, an a-helical Heel, a b-stranded Finger 2,
and three conserved disulﬁde bonds that form a cysteine knot
(Shi and Massague 2003; Thompson et al. 2003). Sequence
comparisons indicate that the highest divergence among
Activin, Nodal, and Vg1/GDF1 is in the N-terminal segment of
Finger 1, the central a-helix, and the loop of Finger 2 with
approximately 10%, approximately 15%, and approximately
25% sequence identity, respectively. These regions are
potential candidates to determine the speciﬁcity of recep-
tor–coreceptor–ligand interactions.
In addition to coreceptors, antagonists represent another
class of extracellular factors that control ligand access to
receptors (reviewed in Piek et al. 1999; Freeman 2000; De
Robertis et al. 2001; Shi and Massague 2003). For example, the
divergent TGFb class of Lefty proteins antagonizes Nodal
signaling (reviewed in Hamada et al. 2002; Schier 2003).
Unlike other TGFbs, Lefty proteins may function as mono-
mers due to the lack of a cysteine residue involved in
dimerization (Meno et al. 1996; Thisse and Thisse 1999;
Sakuma et al. 2002). Lefty overexpression in zebraﬁsh induces
phenotypes identical to cyclops;sqt double mutants and MZoep
mutants (Bisgrove et al. 1999; Meno et al. 1999; Thisse and
Thisse 1999). Furthermore, the loss of Lefty activity leads to
enhanced Nodal signaling during mesoderm induction and
left–right axis determination (Meno et al. 1999, 2001;
Agathon et al. 2001; Branford and Yost 2002; Chen and
Schier 2002; Feldman et al. 2002). Although it has not been
determined whether Lefty directly blocks Vg1/GDF1 signaling
(Branford et al. 2000), it has been proposed that Lefty inhibits
signaling by Activin. Misexpression of Activin or ActRIIB can
overcome the inhibitory effects of Lefty (Meno et al. 1999;
Thisse and Thisse 1999; Cheng et al. 2000; Tanegashima et al.
2000; Sakuma et al. 2002). Hence, some members of the Lefty
family have been called Antivins for their anti-Activin
properties (Thisse and Thisse 1999; Cheng et al. 2000;
Ishimaru et al. 2000; Tanegashima et al. 2000). However, it
has been elusive how Lefty functions at the molecular level.
Here we present genetic and biochemical studies in
zebraﬁsh and Xenopus that indicate that Lefty is an in vivo
antagonist of EGF-CFC coreceptors. We ﬁnd that Lefty can
antagonize signaling by the coreceptor-dependent ligands
Nodal and Vg1/GDF1, but not Activin. Lefty genetically
interacts with Cripto and Oep and competes with Nodal for
binding to Cripto, representing a novel mechanism for
antagonizing TGFb signaling. We identify a short region in
Finger 2 of Activin, Nodal, and Vg1 that determines EGF-CFC
coreceptor-dependent or coreceptor-independent signaling
and governs susceptibility to Lefty. These results indicate that
subtle sequence variations in TGFb ligands can dramatically
expand signaling diversity by determining interactions with
coreceptors and their antagonists.
Results
Lefty Antagonizes Nodal and Vg1 Signaling, but Not
Activin Signaling
TGFb ligands that activate Activin receptors can be
categorized into two classes. The Activin class activates
Activin receptors in an EGF-CFC coreceptor-independent
manner, whereas the Nodal and Vg1/GDF1 classes require
EGF-CFC proteins for receptor activation (Gritsman et al.
1999; Cheng et al. 2003). To determine whether these classes
are also differentially susceptible to inhibition by the TGFb
antagonist Lefty, we coexpre s s e dz e b r a ﬁ s hL e f t y 1w i t h
Xenopus ActivinbB, Xenopus ActivinbA, Sqt (a zebraﬁsh
Nodal-related protein), or zebraﬁsh Vg1 (a chimeric molecule
containing the Xenopus ActivinbB prodomain fused to the
mature domain of zebraﬁsh Vg1) in zebraﬁsh embryos (Smith
et al. 1990; Thomsen et al. 1990; van den Eijnden-Van Raaij et
al. 1990; Helde and Grunwald 1993; Erter et al. 1998; Feldman
et al. 1998; Thisse and Thisse 1999). As a readout for active
signaling, we analyzed the ectopic induction of the Nodal
downstream gene goosecoid (gsc). ActivinbB, ActivinbA, Sqt,
and Vg1-induced ectopic gsc expression in wild-type embryos
(Figure 1D, 1G, 1J, and 1M; Gritsman et al. 1999; Cheng et al.
2003). Coexpression of Lefty1 efﬁciently inhibited gsc
induction by Sqt (Figure 1K and 1L; Bisgrove et al. 1999;
Meno et al. 1999; Thisse et al. 2000) and Vg1 (Figure 1N and
1O), but not ActivinbB or ActivinbA (Figure 1E, 1F, 1H, and
1I). To examine whether Lefty1 can antagonize the induction
of a gene that responds to very low levels of Activin signaling,
we titrated ActivinbB levels so that no tail (ntl; also known as
brachyury/T) expression was only weakly induced (see arrow-
head in Figure 1A). The coexpression of Lefty1 did not inhibit
ntl induction by ActivinbB (Figure 1B and 1C), but inhibited
the dorsal margin expression of ntl that is dependent on
endogenous Nodal signaling (see asterisks in Figure 1B and
1C; Feldman et al. 1998). In a more quantitative assay, we
overexpressed Lefty1, ActivinbB, Sqt, and Vg1 in zebraﬁsh
embryos in the presence of the luciferase reporter A3-luc,
which contains FoxH1/P-Smad2 response elements (Chen et
al. 1996). Consistent with the gsc and ntl induction assays, Sqt
and Vg1 signaling, but not ActivinbB signaling, is inhibited by
Lefty1 (Figure 1P). These results indicate that Lefty1
efﬁciently antagonizes Nodal and Vg1/GDF1 signaling, but
not Activin signaling.
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The molecular mechanism of Lefty action has been
unresolved. Lefty seems to act upstream of the Activin
receptors, as Lefty cannot block signaling from ligand-
independent constitutively activated receptors (Thisse and
Thisse 1999). Our ﬁnding that Lefty blocks Nodal and Vg1
signaling, but not Activin signaling, suggests that Lefty blocks
extracellular components speciﬁc to the Nodal and Vg1
pathways. The only such factors identiﬁed to date are the
EGF-CFC coreceptors. We therefore examined whether the
EGF-CFC genes zebraﬁsh oep and mouse Cripto genetically
interact with Lefty1. Overexpression of Lefty1 in wild-type
zebraﬁsh resulted in embryos lacking head and trunk
mesendoderm due to inhibition of endogenous Nodal signal-
ing (Figure 2A1 and 2A9; Bisgrove et al. 1999; Meno et al.
1999; Thisse and Thisse 1999). Coexpression of Cripto or Oep
partially suppressed Lefty-induced defects (Figure 2B1–2B3;
data not shown), restoring trunk and head mesoderm,
including the notochord, and resulting in the separation of
the eye ﬁeld into two eyes. These results indicate an
antagonistic relationship between EGF-CFC coreceptors
and Leftys.
Lefty Binds to Cripto, but Not to ActRIIB or Alk4
Because Lefty and EGF-CFC proteins interact genetically,
we examined whether Lefty interacts biochemically with
Cripto and/or ActRIIB/Alk4 receptor complexes. We ex-
pressed and immunoprecipitated epitope-tagged ligands
(zebraﬁsh Lefty1/HA [hemagglutinin], zebraﬁsh Lefty1/Glu,
or zebraﬁsh Sqt/HA), receptors (mouse ActRIIB[KR]/Myc and
human Alk4[KR]/Flag), and a coreceptor (mouse Cripto/Flag)
in Xenopus embryos (Yeo and Whitman 2001; Cheng et al.
2003). Similar to other Nodal-related proteins (Reissmann et
al. 2001; Yeo and Whitman 2001; Bianco et al. 2002; Sakuma
et al. 2002; Yan et al. 2002), Sqt formed a complex with the
type II receptor ActRIIB, type I receptor Alk4, and Cripto
(Figure 3A). In contrast, Lefty1 coimmunoprecipitated
Cripto, but not ActRIIB or Alk4 (Figure 3A). Since Cripto is
bound to Alk4 even in the absence of ligand (Reissmann et al.
2001; Yeo and Whitman 2001; Bianco et al. 2002; Yan et al.
2002), Lefty seemed to disrupt the Cripto–Alk4 interaction.
In reverse experiments, Cripto efﬁciently coimmunoprecipi-
tated Lefty1 (Figure 3B). Since Sqt and Lefty1 can both bind
to Cripto (Figure 3C; Reissmann et al. 2001; Yeo and
Whitman 2001; Bianco et al. 2002; Sakuma et al. 2002; Yan
et al. 2002), these two ligands might compete for binding to
Cripto. Indeed, the coexpression of Lefty1 led to decreased
interactions between Cripto and Sqt (Figure 3C). To
determine whether Cripto can directly interact with Lefty,
we immunoprecipitated puriﬁed mouse Lefty1 protein
(mLefty1) in the presence of either puriﬁed mouse Cripto
protein or a control cysteine-rich protein, mouse vascular
endothelial growth factor-D (VEGF-D). mLefty1 protein
directly interacted with Cripto, but not with VEGF-D.
Together, these results suggest that Lefty inhibits Nodal
signaling by associating with Cripto and blocking it from
interacting with Nodal.
Activin Loop-b8 Region Confers EGF-CFC Coreceptor
Independence to Sqt
The ﬁnding that TGFb ligands that activate Activin
receptors can be grouped into a EGF-CFC coreceptor-
dependent class that is susceptible to inhibition by Lefty
(Nodal and Vg1) and a class that is independent of EGF-CFC
proteins and resistant to Lefty (Activin) prompted us to
examine which sequences underlie this ligand diversity. We
therefore generated chimeras between Activins (EGF-CFC-
independent) and Sqt or Vg1 (EGF-CFC-dependent) (Figures
Figure 1. Lefty Antagonizes Nodal and
Vg1 Signaling, but Not Activin Signaling, in
Zebrafish
ntl mRNA expression (A–C) and gsc
mRNA expression (D–O) in wild-type
zebraﬁsh embryos at shield stage, animal
pole view. Embryos were injected with
low levels (1 pg) of activin bB mRNA (A–
C), high levels (10 pg) of activin bB mRNA
(D–F), 200 pg of activin bA mRNA (G–I),
75 pg of sqt mRNA (J–L), or 200 pg of Vg1
(M–O). Embryos were further double-
injected with either 500 pg of LacZ
mRNA (A, D, G, J, and M), 100 pg of
lefty1 and 400 pg of LacZ mRNAs (B, E, H,
K, and N), or 500 pg of lefty1 mRNA (C, F,
I, L, and O). Ectopic ntl expression
(arrowheads) in activin bB mRNA-in-
jected embryos was not inhibited by
Lefty1 (B and C) when compared with
LacZ mRNA-coinjected controls (A).
Note the dorsal expression of ntl (aster-
isks)—that is, dependent on endogenous
Nodal signaling—is inhibited by Lefty1
in these embryos (B and C). Ectopic gsc
expression in activin bB and activin bA mRNA-injected embryos was not inhibited by Lefty1 (E and F and H and I, respectively). In contrast,
ectopic gsc expression in sqt and Vg1 mRNA-injected embryos was inhibited by both levels of Lefty expression (K and L and N and O,
respectively). Wild-type embryos (P) were injected with 10 pg (low) and 20 pg (high) of activin bB/HA, 75 pg of sqt, or 200 pg of Vg1 mRNA.
Embryos were further double-injected with 500 pg of LacZ mRNA, 100 pg of lefty1, and 400 pg of LacZ mRNAs, or 500 pg of lefty1 mRNA. Smad2
pathway activation was measured by an Activin response element luciferase reporter, A3-luc. Values are folds over wild-type control injected
with 500 pg of LacZ mRNA and A3-luc reporter. An asterisk indicates a signiﬁcant difference from the level of activation with ligand and LacZ
expression alone (Student’s t-test, p , 0.05).
DOI: 10.1371/journal.pbio.0020030.g001
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encoding these chimeric ligands into wild-type and MZoep
zebraﬁsh embryos and analyzed the ectopic induction of the
downstream genes ntl and gsc. Sqt, Vg1, and Activins induced
these genes in wild-type embryos, allowing us to determine
which chimeric ligands were active. Activins, but not Sqt or
Vg1, were active in MZoep mutants, allowing us to test which
sequences conferred EGF-CFC coreceptor dependence or
independence.
Initially, swaps of the Finger 1, Heel, or Finger 2 domains of
Sqt and ActivinbB were generated. As shown in Figure 4, the
Finger 2 region of ActivinbB contains sequence determinants
Figure 3. Lefty Binds to Cripto, but Not to
the Activin Receptors ActRIIB and Alk4
(A and B) Lefty1 interacts with Cripto.
RNAs (1 ng each) encoding ActRIIB(KR)/
Myc, Alk4(KR)/Flag, Cripto/Flag, Lefty1/
HA, or Sqt/HA were injected into Xen-
opus embryos. After chemical cross-link-
ing, lysates were immunoprecipitated for
either Lefty1/HA or Sqt/HA (A) with
anti-HA antibody, or ActRIIB(KR)/Myc,
Alk4(KR)/HA, Cripto/Flag (B) with, re-
spectively, anti-Myc, anti-HA, or anti-
Flag antibodies. Note that Lefty1 specif-
ically interacts with Cripto (A and B),
and these Lefty/Cripto complexes do not
contain Alk4 (A). Moreover, processed
Lefty1 binds much more efﬁciently to
Cripto than full-length Lefty1 precursor
(B). In contrast, Sqt can bind to ActRIIB,
Alk4, and Cripto (A). The 55 kDa protein
marker in (B) is estimated based on
molecular weight markers.
(C) Lefty1 competes with Nodal for
binding to Cripto. RNAs encoding Sqt/HA (1 ng), Cripto/Flag (100 pg), or Lefty1 (2 ng) were injected and anti-Flag antibody was used to
immunopreciptate Cripto/Flag.
(D) mLefty1 binds directly to Cripto. Puriﬁed mouse Lefty1 protein (mLefty1; 10 lg/ml) was mixed with either soluble puriﬁed Cripto/His
protein (5 lg/ml) or puriﬁed control VEGF-D/His protein (5 lg/ml). After chemical cross-linking, mLefty1 was immunoprecipitated with anti-
mLefty1 antibody. mLefty1 associates with Cripto, but not with control VEGF-D.
Proteins in the coimmunoprecipitates and total extracts were probed in Western blot analysis with the indicated antibodies: ActRIIB(KR)/Myc
(kinase-defective receptor, approximately 120 kDa; anti-Myc), Alk4(KR)/Flag (kinase-defective receptor, approximately 70 kDa; anti-Flag),
Cripto/Flag (approximately 30 kDa; anti-Flag), Lefty1/HA (mature ligand, approximately 36–40 kDa; anti-HA; Sakuma et al. 2002), Sqt/HA
(unprocessed precursor, approximately 55 kDa; mature ligand, approximately 22 kDa; anti-HA), Lefty1/Glu (unprocessed precursor,
approximately 55 kDa; mature ligand, approximately 38 kDa; anti-Glu; Sakuma et al. 2002), mLefty1 (mature ligand, approximately 36 kDa,
anti-mLefty1; Sakuma et al. 2002), Cripto/His (soluble form, approximately 22–25 kDa; anti-His), and VEGF-D/His (mature ligand, approximately
15–20 kDa; anti-His).
DOI: 10.1371/journal.pbio.0020030.g003
Figure 2. EGF-CFC Coreceptors Genetically
Interact with Lefty
Live wild-type zebraﬁsh embryos at 30 h
postfertilization (hpf).
(A1, B1, and C1) Ventral views of the
head.
(A19, B2, B3, and C19) Lateral views, with
anterior to the left, dorsal up.
(A1, A19, B1, B2, and B3) Wild-type
embryos were injected with 20 pg of
lefty1 mRNA. Embryos were further
double-injected with either 200 pg of
LacZ mRNA (A1 and A19) or 200 pg of
Cripto mRNA (B1, B2, and B3).
(C1 and C19) Wild-type embryos injected
with 200 pg of Cripto mRNA and 20 pg of
LacZ mRNA.
Misexpression of Lefty1 results in cyclo-
pia and other head and trunk mesoderm
defects ([A1 and A19] 32 of 32 embryos
had the phenotype shown; arrow shows
cyclopia). Coexpression of Cripto with
Lefty in embryos leads to rescue of two
eyes ([B1] four of 50; arrows show two
eyes), notochord ([B2] 20 of 50; inset
shows trunk somites and notochord, red
bar delineates notochord), and trunk
somites ([B3] 50 of 50). Embryos injected
with Cripto mRNA only show normal
wild-type phenotype ([C1 and C19] 30 of 30; arrow in [C1] shows two normal eyes, and inset in [C19] shows normal notochord and trunk
somites, red bar delineates notochord).
DOI: 10.1371/journal.pbio.0020030.g002
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TGFb Signaling Determinantsthat conferred EGF-CFC-independent activity on chimeric
ligands. Chimeric SSA, ASA, and SAA that contain the Finger
2 region of ActivinbB were active in both wild-type and
MZoep embryos (Figure 4). To further delineate this region,
we generated additional chimeras (Figure 5B). Short stretches
of full-length Sqt were replaced by the corresponding region
of ActivinbB, including the b6b7, loop, b8, or b9 subregions
(Figure 5A and 5B; data not shown). Analysis of these
chimeras revealed that the 14 amino acids encoding the loop
and b8 region of ActivinbB (Sqt
ActbB[loopb8]; the bracketed
region in superscript denotes substituted domains) were
sufﬁcient to confer EGF-CFC independence. Further dis-
section of this region into loop alone (Sqt
ActbB[loop])o rb8
alone (Sqt
ActbB[b8]) yielded no or much weaker activity in
MZoep mutants as compared with wild-type embryos (Figure
5B and 5C). These results suggest that a 14 amino acid region
in Activin is sufﬁcient to confer EGF-CFC independence
when placed into Sqt.
Activin Loop-b8 Region Confers EGF-CFC Coreceptor
Independence to Vg1
To determine whether the loop-b8 region has a wider role
in conferring coreceptor independence, we generated addi-
tional chimeras using ActivinbA (another EGF-CFC-inde-
pendent ligand) and Vg1. Sqt
ActbA[loopb8] (full-length Sqt with
an ActivinbA loop-b8 region) and Vg1
ActbB[loopb8] (Vg1 with
an ActivinbB loop-b8 region) both induced gsc expression in
MZoep m u t a n t sw i t hs i m i l a re f ﬁ c i e n c i e sa si nw i l d - t y p e
embryos (Figure 5D). These results were also corroborated
using the A3-luc reporter assay (Figure 5E) and suggest that
the loop-b8 region has a general role in conferring EGF-CFC
coreceptor independence.
Activin Loop-b8 Region Confers Binding to Activin
Receptors in the Absence of EGF-CFC Coreceptors
Sqt
ActbB[loopb8] can signal in an EGF-CFC-independent
manner in vivo, suggesting that this chimeric protein might
bind to ActRIIB and Alk4 receptors in the absence of EGF-
CFC coreceptors. To test this idea, we coexpressed and
immunoprecipitated epitope-tagged ligands (ActivinbB/HA,
Sqt/HA, Sqt
ActbB[loopb8]/HA), receptors (ActRIIB[KR]/Myc and
Alk4[KR]/Flag), and a coreceptor (Cripto/Flag) in Xenopus
embryos (Yeo and Whitman 2001; Cheng et al. 2003). We
found that Sqt binding to the ActRIIB and Alk4 receptor
complex required Cripto (Figure 5F). In contrast, ActivinbB
and Sqt
ActbB[loopb8] can bind to Activin receptors in the
absence of Cripto. Moreover, Cripto did not signiﬁcantly
increase Sqt
ActbB[loopb8] ligand–receptor complex formation.
These results indicate that the loop-b8 region is a determi-
nant of TGFb ligand binding to Activin receptors independ-
ent of EGF-CFC coreceptors.
Multiple Residues in the Loop-b8 Region Contribute to
Coreceptor Independence
An alignment of the loop-b8 region of EGF-CFC-depend-
ent and EGF-CFC-independent TGFbs (Figure 5A) reveals the
Figure 4. Chimera Analysis to Identify
TGFb Sequence Determinants Conferring
EGF-CFC Coreceptor Dependence or Inde-
pendence
Schematic depiction of chimeras of
mature ligand domains, Finger 1 (F1),
Heel (H), and Finger 2 (F2), between
Xenopus ActivinbB and zebraﬁsh Sqt. HA
indicates an hemagglutinin epitope tag.
Schematic is not drawn to scale. The
letters in these three-lettered (XXX)
chimeras represent the Finger 1, Heel,
and Finger 2, respectively. S denotes
Squint; A denotes ActivinbB. Synthetic
mRNAs (200 pg) encoding chimeras were
injected into wild-type and MZoep em-
bryos. gsc and ntl mRNA expression is
shown at shield stage; animal pole views
are dorsal to the right. gsc is expressed in
the dorsal organizer (shield) in wild-type
embryos, but is absent in MZoep mutants.
ntl is expressed around the entire margin
in wild-type embryos, but the dorsal
margin expression is lost in MZoep
mutants. The presence of the ActivinbB
prodomain and epitope tag does not
alter the speciﬁcity or functionality of
wild-type ActivinbB (AAA) or Sqt (SSS).
AAA can induce ectopic gsc and ntl
expression in both wild-type and MZoep
embryos. In contrast, SSS can induce
ectopic gsc and ntl expression in only
wild-type embryos. Similar to ActivinbB,
chimeras SSA, SAS, ASA, and SAA can
induce ectopic gsc and ntl expression in
b o t hw i l d - t y p ea n dM Z oep embryos.
Chimeras ASS and AAS are inactive in
b o t hw i l d - t y p ea n dM Z oep embryos.
Western blot analysis indicated that all
chimeric constructs produce stable li-
gands (data not shown).
DOI: 10.1371/journal.pbio.0020030.g004
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TGFb Signaling DeterminantsFigure 5. Sequence Determinants Conferring Independence from EGF-CFC Coreceptors
(A) Sequence alignment of Finger 2 region of EGF-CFC-dependent and EGF-CFC-independent TGFb ligands. Location of secondary structure
elements, b-sheets (b6–b9) and loop, are shown (Kirsch et al. 2000). Residue numbering is from mouse ActivinbA.
(B–E) Synthetic mRNAs (200 pg) encoding chimeras of Finger 2 subregions between Xenopus ActivinbB or ActivinbA and zebraﬁsh Sqt or Vg1
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TGFb Signaling Determinantspresence of several residues unique to Activins. These include
(i) a Lys102–X–Asp104 motif (numbering from ActivinbA)
that forms a signiﬁcant binding interface with the type II
receptor ActRII (Wuytens et al. 1999; Greenwald et al. 2003;
Thompson et al. 2003); (ii) Gln/Pro106 and Asn107, which
contribute to the dimerization interface responsible for
conformational arrangement (Thompson et al. 2003); and
(iii) an Asn insertion at position 99. We therefore mutated the
corresponding residues in Sqt, individually or in combina-
tion, to the ActivinbB sequence and tested them in the gsc/ntl
induction assay (Figure 6). All constructs were active in wild-
type embryos. The Sqt3 and Sqt5 constructs containing the
Lys102–X–Asp104 motif and Asn99 insertion showed weak
expansion of ntl expression animally and dorsally in MZoep
mutants. The incorporation of Pro106–Asn107 (Sqt2, Sqt4,
and Sqt5) in Sqt did not enhance activity in MZoep mutants.
These results suggest that multiple residues contribute to
coreceptor independence, with the type II receptor-binding
interface being an essential determinant.
The Loop-b8 Region in Sqt Is Inhibitory
The results described above identiﬁed the loop-b8 region
of Activin as a region that confers coreceptor-independent
signaling to ligands that are normally EGF-CFC-dependent.
In a reverse set of experiments, we asked which regions
confer dependence on EGF-CFC coreceptors. To identify
domains that confer EGF-CFC dependence, chimeras be-
tween ActivinbB and Sqt (see Figures 4 and 7) were analyzed
for their inability to signal in MZoep mutants. Chimeras
containing the Sqt Finger 2 domain (AAS and ASS; see Figure
4) or only the Sqt loop-b8 region (Act
Sqt[loopb8]; Figure 7) were
inactive in both wild-type and MZoep embryos. Western blot
analysis demonstrated that these chimeras generate stable
ligands (data not shown). The addition of Finger 1 in SAS or
Act
Sqt[Finger1-loopb8] relieved the inhibitory effect of the loop-
b8 region of Sqt in wild-type embryos (Figure 7). These
chimeras were inactive in MZoep mutants. These results
indicate that the loop-b8 region in Sqt acts as an inhibitory
domain and that Finger 1 relieves this inhibition by
conferring dependence on EGF-CFC coreceptors.
Specificity of Antagonism by Lefty Is Determined by EGF-
CFC Coreceptor Dependence
Our genetic and biochemical studies suggested that Lefty
blocks Nodal and Vg1 signaling via EGF-CFC coreceptors. In
contrast, the coreceptor-independent signaling by Activins
cannot be blocked by Lefty. This ﬁnding predicts that the




ActbB[loopb8] should also be resistant
to Lefty. Conversely, the coreceptor-dependent chimera
Act
Sqt[Finger1-loopb8] should be suspectible to inhibition by
Lefty. To test this hypothesis, we coexpressed chimeric
ligands and Lefty1 and analyzed gsc expression and A3-luc
reporter induction (Figure 8A–8M). As predicted, Lefty1 did
not inhibit signaling by Sqt
ActbB[loopb8] (Figure 8B and 8C),
Sqt
ActbA[loopb8] (Figure 8E and 8F), or Vg1
ActbB[loopb8] (Figure
8H and 8I), but antagonized Act
Sqt[Finger1-loopb8] (Figure 8K
and 8L). These results indicate that the incorporation of the
Activin loop-b8 region into Nodal and Vg1 can render these
ligands EGF-CFC-independent and therefore resistant to
Lefty.
Discussion
Lefty Antagonizes EGF-CFC Coreceptors
Lefty molecules are key regulators of mesendoderm
development and left–right axis determination, but the
molecular basis of Lefty-mediated antagonism of Activin-like
pathways has been elusive (Hamada et al. 2002; Schier 2003).
Our genetic and biochemical studies provide three lines of
evidence that Lefty blocks EGF-CFC coreceptors. First, Lefty
only inhibits EGF-CFC-dependent TGFb ligands such as
Nodal and Vg1, but not EGF-CFC-independent ligands such
as Activins. A striking example of this coreceptor-speciﬁc
interaction is the ﬁnding that changing only 14 amino acids
in Nodal or Vg1 to the corresponding residues in Activins
renders the resulting TGFb ligands independent of EGF-CFC
coreceptors and resistant to Lefty. Second, the EGF-CFC
proteins mouse Cripto and zebraﬁsh Oep can partially
suppress the effects of Lefty overexpression in zebraﬁsh.
Third, Leftys can bind to EGF-CFC coreceptors and block the
coreceptors from interacting with Nodal. Furthermore, Lefty/
EGF-CFC complexes seem to exclude interactions with type I
and type II Activin receptors. Taken together, these results
indicate that Lefty blocks a subset of TGFb signals by the
novel mechanism of blocking pathway-speciﬁc coreceptors
(Figure 9A–9D).
The observation that Lefty does not block signaling by
Activin seems in apparent contrast to previous studies that
led to naming some Lefty family members Antivins, for their
anti-Activin properties (Thisse and Thisse 1999; Cheng et al.
2000; Ishimaru et al. 2000; Tanegashima et al. 2000). In
particular, it has been found that misexpression of Activin
can suppress the defects caused by Lefty misexpression in
vivo (Thisse and Thisse 1999). Our results do not undermine
this ﬁnding, but suggest an alternative explanation. Previous
studies have shown that Activin can suppress the loss of EGF-
were injected into wild-type and MZoep embryos. Schematic is not drawn to scale. gsc and ntl mRNA expression is at shield stage; animal pole
views are dorsal to the right.
(B) Sqt
ActbB[loopb8b9] and Sqt
ActbB[loopb8] can induce gsc and ntl expression in both wild-type and MZoep embryos.
(C) Sqt
ActbB[b8] can weakly expand ntl expression in MZoep mutants. ntl mRNA expression in MZoep mutants is at shield stage; lateral view.
(D) Other TGFbs conform to loop-b8 EGF-CFC-independent determinant. Note that Xenopus ActivinbA can induce ectopic gsc in both wild-type
and MZoep embryos. In contrast, Vg1 can only induce gsc in wild-type embryos. Similar to Activins, chimeric Sqt
ActbA[loopb8] and Vg1
ActbB[loopb8]
can induce ectopic gsc in both wild-type and MZoep embryos.
(E) Wild-type and MZoep embryos were injected with 5 pg of activin bB, 100 pg of sqt, 100 pg of Vg1, 125 pg of Sqt
ActbB[loopb8], 250 pg of
Sqt
ActbA[loopb8], or 100 pg of Vg1
ActbB[loopb8] mRNA. Smad2 pathway activation was measured by an Activin response element luciferase reporter, A3-
luc. Luciferase units are relative to wild-type or MZoep control injected with the A3-luc reporter alone.
(F) Sqt
ActbB[loopb8] can bind to ActRIIB and Alk4 in the absence of EGF-CFC coreceptors. RNAs (1 ng each) encoding ActRIIB(KR)/Myc, Alk4(KR)/
Flag, Cripto/Flag, ActivinbB/HA, Sqt/HA, or Sqt
ActbB[loopb8]/HA were injected into Xenopus embryos. Proteins in the coimmunoprecipitates and
total extracts were probed in Western blot analysis with the indicated antibodies: ActRIIB(KR)/Myc (approximately 120 kDa; anti-Myc), Alk4(KR)/
Flag (approximately 70 kDa; anti-Flag), Cripto/Flag (approximately 30 kDa; anti-Flag), ActivinbB/HA (mature ligand, approximately 16 kDa; anti-
HA), Sqt/HA (mature ligand, approximately 22 kDa; anti-HA), and Sqt
ActbB[loopb8]/HA (mature ligand, approximately 22 kDa; anti-HA).
DOI: 10.1371/journal.pbio.0020030.g005
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TGFb Signaling DeterminantsCFC activity in MZoep mutants (Gritsman et al. 1999; Cheng et
al. 2003). Analogously, we suggest that the blocking of EGF-
CFC activity by Lefty can be bypassed by Activin, because this
ligand can activate Activin receptors independent of co-
receptors. A similar scenario can also account for the
suppression of Lefty gain-of-function phenotypes by mis-
expression and activation of Activin receptors (Meno et al.
1999; Thisse and Thisse 1999; Sakuma et al. 2002). Hence,
Activin and Activin receptors bypass the loss of EGF-CFC
coreceptor function that is caused either by mutations in oep
or by overexpression of Lefty. Conversely, Lefty cannot block
Activin signals and Activin receptors because of their
independence from EGF-CFC coreceptors.
Is the block of EGF-CFC coreceptors by Lefty a general and
conserved mechanism? Although we have only analyzed a
representative subset of these protein families (zebraﬁsh and
mouse Lefty1; zebraﬁsh Oep; mouse Cripto; zebraﬁsh Sqt),
previous studies have suggested that heterologous Nodal,
Lefty, and EGF-CFC proteins have similar activities in
zebraﬁsh (Schier 2003). For example, mouse Nodal, mouse
Lefty2, and mouse Cripto are active in zebraﬁsh, despite less
than 30% overall sequence conservation with their zebraﬁsh
counterparts (Toyama et al. 1995; Meno et al. 1999; Gritsman
et al. 1999). These studies suggest that the molecular
mechanisms described here apply to most, if not all, Nodal/
Lefty/EGF-CFC interactions. This does not exclude the
possibility that Lefty has additional means of blocking TGFb
signaling. First, Leftys might block the processing of Nodals.
However, Sqt is processed normally at levels of Lefty that
block Nodal signaling (unpublished data). Second, Leftys
might bind Nodal signals. This could result in blocking
receptor interactions or antagonizing TGFb dimerization.
However, Sqt is not bound by Lefty at Lefty levels that block
Nodal signaling and lead to complex formation with Cripto
(unpublished data). Moreover, a Sqt protein containing the
loop-b8 region of Activin is resistant to Lefty, whereas
changing only the dimerization residues in this region does
not confer resistance. Third, Leftys might interact with
additional extracellular factors. Indeed, the overexpression
of the extracellular domain of the type II receptor ActRIIB has
been shown to suppress Lefty activity (Meno et al. 1999).
Although zebraﬁsh Lefty1 does not appear to bind to ActRIIB,
it is conceivable that overexpression of soluble ActRIIB might
protect EGF-CFC coreceptors or another yet-to-be identiﬁed
protein from antagonism by Lefty. In addition, overexpres-
sion of EGF-CFC proteins in zebraﬁsh does not induce
dominant phenotypes (Gritsman et al. 1999). It is therefore
possible that an additional factor would be required to
completely block Lefty in these experiments. Alternatively,
overexpression levels of EGF-CFC coreceptors might not be
high enough to block Lefty at blastula stages. It is also possible
that coreceptor overexpression might block Nodal signals,
because it has been shown that EGF-CFC proteins and Nodals
can directly interact. The complex feedback interactions
between Lefty and Nodal might also overcome an initial
reduction of Lefty activity by increasing Lefty transcription.
These considerations and the data presented here therefore
suggest that a major, but perhaps not exclusive, role of Leftys
is to block a subset of TGFb signals by interaction with EGF-
CFC coreceptors.
Implications for the Role of Lefty during Development
Our ﬁnding that Leftys can block Vg1 signaling also has
important implications for the developmental control of
TGFb signaling. Based on previous studies revealing that
Lefty proteins inhibit Nodal signaling, the mouse Lefty
mutant phenotypes have been interpreted as a consequence
of increased or sustained Nodal signaling (Hamada et al. 2002;
Schier 2003). For example, loss of mouse Lefty2 has been
thought to increase Nodal signaling, resulting in an enlarged
primitive streak (Meno et al. 1999). Similarly, the left–right
defects observed in mouse Lefty1 and left-side speciﬁc Lefty2
(Lefty2
DASE) mutants have been thought to be caused by
inappropriate spread of Nodal signaling (Meno et al. 1998,
2001). Our ﬁnding that Vg1/GDF1 signaling can also be
blocked by Lefty suggests a more complex scenario. In
particular, GDF1 (the mouse homologue of Vg1) is required
for proper left–right axis determination (Rankin et al. 2000).
GDF1 mutants appear to have the opposite phenotypes as
Lefty1 and Lefty2
DASE mutants. While GDF1 promotes the
expression of left-side-speciﬁc genes such as Pitx2 on the left,
Leftys appear to block Pitx2 expression on the right (Meno et
al. 1998, 2001; Rankin et al. 2000). In light of our ﬁndings, we
suggest that during left–right axis formation, Leftys act as
antagonists of not only Nodal, but also GDF1. In this scenario,
loss of Lefty1 or Lefty2 would lead to ectopic and sustained
Figure 6. Conserved Residues in Activin
Loop-b8 Region Confer Independence
from EGF-CFC Coreceptors
Synthetic mRNAs (200 pg) encoding Sqt
harboring multiple mutations from
ActivinbB (shown in red) were injected
intowild-typeandMZoepembryos.gscand
ntl mRNA expression is shown at shield
stage; animal pole views are dorsal to the
right. Schematic is not drawn to scale.
Note that the Sqt3 and Sqt5 constructs
containing the Lys102–X–Asp104 motif
andAsn99insertionshowweakexpansion
of ntl expression animally and dorsally in
MZoep mutants.
DOI: 10.1371/journal.pbio.0020030.g006
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TGFb Signaling DeterminantsGDF1 signaling. This model is particularly attractive when
one considers the expression patterns of Lefty1, Lefty2, the
EGF-CFC gene Cryptic, Nodal, and GDF1. Lefty 1 and GDF1 are
coexpressed in the developing midline (Meno et al. 1996,
1997; Rankin et al. 2000), whereas Lefty2 and Nodal are
coexpressed in left-lateral plate mesoderm (Conlon et al.
1994; Meno et al. 1997). Cryptic is expressed in both the lateral
plate and midline (Shen et al. 1997). It is therefore
conceivable that GDF1 signaling is restricted by Lefty1-
mediated inhibition of Cryptic in the midline and its
progenitors, whereas Nodal signaling is antagonized by
Lefty2-mediated block of Cryptic in the lateral plate.
Our results might also have implications for the role of
Cripto in tumorigenesis. Cripto is highly overexpressed in
human epithelial cancers, such as breast and colon carcino-
mas (Salomon et al. 2000), and has been implicated in tumor
formation (Ciardiello et al. 1991, 1994; Baldassarre et al. 1996;
De Luca et al. 2000; Salomon et al. 2000; Adkins et al. 2003).
Although the mechanisms by which Cripto acts in these
circumstances are unclear, inhibition of Cripto by antisense
or antibody blockade can inhibit tumor cell proliferation
(Ciardiello et al. 1994; Baldassarre et al. 1996; De Luca et al.
2000; Adkins et al. 2003; reviewed by Shen 2003). Since Lefty
is an in vivo antagonist of EGF-CFC activity, it might also
serve as a therapeutic agent to block Cripto.
Subtle Sequence Differences Determine the Interaction
with Coreceptors and Inhibitors
The ﬁnding that the highly related ligands Activin, Nodal,
and Vg1/GDF1 activate the same receptors but differ in their
dependence on coreceptors allowed us to determine how
ligand diversity and signaling speciﬁcity can be achieved. We
have identiﬁed the loop-b8 region as a 14 amino acid domain,
a mere 4% of the entire TGFb signal, that contributes to
coreceptor dependence or independence. Sqt and Vg1
incorporating the loop-b8 region of Activin can bind to the
Activin receptors in the absence of EGF-CFC proteins.
Conversely, Activin incorporating the loop-b8 region of Sqt
is inactive, suggesting that the Nodal/Vg1 loop-b8 region
might be inhibitory. This inhibition can be relieved by the
Finger 1 domain of Sqt, which results in the dependence on
EGF-CFC coreceptors (Figure 9D). These results indicate that
rather subtle sequence variations can lead to striking changes
in ligand diversity.
Structural considerations suggest that the loop-b8 region
determines coreceptor independence or dependence at least
in part by its interactions with type II receptors. The
Figure 8. EGF-CFC Coreceptor Depen-
dence Determines Susceptibility to Antag-
onism by Lefty
(A–L) Embryos were injected with 75 pg
of Sqt
ActbB[loopb8] mRNA (A–C), 75 pg of
Sqt
ActbA[loopb8] mRNA (D–F), 200 pg of
Vg1
ActbB[loopb8] mRNA (G–I), or 200 pg
Act
Sqt[Finger1-loopb8] mRNA (J–L). Embryos
were further double-injected with either
500 pg of LacZ mRNA (A, D, G, and J),
100 pg of lefty1 and 400 pg LacZ mRNAs
(B, E, H, and K), or 500 pg of lefty1 mRNA
(C, F, I, and L). gsc mRNA expression in
wild-type zebraﬁsh embryos is shown at
shield stage, animal pole view. Note that
both levels of Lefty1 cannot inhibit the
ectopic gsc expression induced by
Sqt
ActbB[loopb8] (B and C), Sqt
ActbA[loopb8]
(E and F), and Vg1
ActbB[loopb8] (H and I).
In contrast, Lefty1 can inhibit
Act
Sqt[Finger1-loopb8] (K and L).
(M) Wild-type embryos were injected with 75 pg of either Sqt
ActbB[loopb8], Sqt
ActbA[loopb8], Vg1
ActbB[loopb8], or 200 pg of Act
Sqt[Finger1-loopb8] mRNA.
Embryos were further double-injected with 500 pg of LacZ mRNA, 100 pg of lefty1, and 400 pg of LacZ mRNAs, or 500 pg of lefty1 mRNA. Smad2
pathway activation was measured by an Activin response element luciferase reporter, A3-luc. Values are folds over wild-type control injected
with 500 pg of LacZ mRNA and A3-luc reporter. An asterisk indicates a signiﬁcant difference from the level of activation with ligand and LacZ
expression alone (Student’s t-test, p , 0.05).
DOI: 10.1371/journal.pbio.0020030.g008
Figure 7. Sequence Determinants Confer-
ring EGF-CFC Dependence
Synthetic mRNAs (200 pg) encoding
ActivinbB with single or double region
substitutions from Sqt were injected into
wild-type and MZoep embryos. gsc and ntl
mRNA expression is shown at shield
stage; animal pole views are dorsal to
the right. Schematic is not drawn to
scale. HA indicates a hemagglutinin
epitope tag. Note that Act
Sqt[loopb8] con-
taining the loop-b8 region of Sqt is
inactive in both wild-type and MZoep embryos. In Act
Sqt[Finger1-loopb8], the additional substitution of Sqt Finger 1 region relieves the inhibitory
presence of the Sqt loop-b8 region. Similar to Sqt, Act
Sqt[Finger1-loopb8] can induce ectopic gsc and ntl in wild-type, but not in MZoep embryos.
Western blot analysis indicates that these chimeric constructs produce stable ligands (data not shown).
DOI: 10.1371/journal.pbio.0020030.g007
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region has been shown to be important for high-afﬁnity
binding to the ActRII receptor (Wuytens et al. 1999;
Greenwald et al. 2003; Thompson et al. 2003). In the crystal
structure of the ActivinbA-ActRIIB complex, Lys102–X–
Asp104 forms an intramolecular salt bridge that interacts
with a hydrophobic interface on ActRIIB (Thompson et al.
2003). Mutational analysis has shown that substituting
Lys102 with a neutral charge (Ala) signiﬁcantly reduces
receptor binding afﬁnity and signaling (Wuytens et al. 1999).
In contrast to Activin, EGF-CFC-dependent ligands such as
Nodals and Vg1/GDF1 have the differentially charged
residues Met/Leu102 and His104 at the corresponding
positions (numbering according to ActivinbA). Similarly, in
BMP7 the corresponding residues are Leu102 and Lys104. It
has been shown that modeling Lys onto the aligned 102
residue in BMP7 positions it within hydrogen-bonding
distance to Glu29 of ActRII and may allow for greater
hydrophobic packing at the interface (Greenwald et al.




ActbB[loopb8], Sqt3, and Sqt5 are corecep-
tor-independent because of their favorable binding to
ActRIIB receptors. Conversely, the corresponding region in
Sqt and Vg1 might be inhibitory because of inefﬁcient
interaction with ActRIIB receptors. Detailed structural
studies should reveal whether EGF-CFC proteins overcome
this inhibition by changing the conformation of Nodal and
Vg1 or by providing an additional interaction surface that
allows the assembly of receptor complexes.
In summary, our results lead to two major conclusions.
First, Lefty inhibits a subset of TGFb signals by using the
novel mechanism of blocking pathway-speciﬁc coreceptors
belonging to the EGF-CFC family. Second, subtle sequence
changes in TGFbs determine their signaling speciﬁcity and
dependence on coreceptors. Although Drosophila has an
Activin signaling pathway, Nodals, Leftys, and EGF-CFC
proteins seem to be restricted to chordates (Brummel et al.
1999; Schier 2003). The evolution of Activin-like signaling
pathways therefore represents a remarkable example of how
a simple signaling pathway consisting of ligand and receptors
can be diversiﬁed by subtle sequence changes that modulate
the interaction with coreceptors and their inhibitors.
Materials and Methods
Strains and embryos. Adult homozygous ﬁsh for oep
tz57 were
generated as described previously (Zhang et al. 1998; Gritsman et al.
1999). Xenopus embryos were obtained as described in Hemmati-
Brivanlou et al. (1992).
Generation of constructs. Epitope-tagged and chimeric constructs
were made using PCR-based methods and conﬁrmed by sequencing.
pCS2-zebraﬁsh Lefty1/HA and Lefty1/Glu constructs were generated
by inserting three tandem copies of HA-epitope or Glu-epitope,
respectively, after Val145. The initial three-lettered (XXX) Sqt/
ActivinbB chimeras were generated by subcloning the prodomain
of Xenopus ActivinbB (codons Met1 to Gly256) fused to an HA-
epitope/XhoI fragment (YPYDVPDYALE) and followed by the mature
chimeric ligand into pcDNA3 vector. S denotes Sqt; A denotes
ActivinbB. The boundaries for Sqt mature ligand domains are as
indicated: Finger 1 (Asn263 to Cys325), Heel (Pro326 to Cys358), and
Finger 2 (Val359 to His392). The boundaries for Xenopus ActivinbB
mature ligand domains are as indicated: Finger 1 (Cys215 to Cys299),
Heel (Pro300 to Cys335), and Finger 2 (Ile336 to Ala370). Full-length
chimeras were generated by incorporating the indicated regions into
Sqt, ActivinbB, or zebraﬁsh Vg1, which were then subcloned into the
pT7TS vector (Ekker et al. 1995). The boundaries for Sqt Finger 2
structural subregions are as indicated: b6b7 (Val359 to Try370), loop
(Tyr371 to Met376), b8 (Val377 to Gly383), and b9 (Met384 to His392).
The boundaries for Xenopus ActivinbB Finger 2 structural subregions
are as indicated: b6b7 (Ile336 to Try347), loop (Phe348 to Ile354), b8
(Val355 to Asn356), and b9 (Met357 to Ala370). The Xenopus
ActivinbA loop-b8 region sequence is FDRNNNVLKTDIAD (also
identical in Xenopus ActivinbD). The zebraﬁsh Vg1 loop-b8 region is
from Try332 to Asp345. pcDNA3-zebraﬁsh Vg1/HA, pcDNA3-Squint/
HA, pCS2-Alk4(KR)/Flag (a kinase-defective mutant of human Alk4
with Lys234 to Arg234 substitution), pCS2-ActRIIB(KR)/Myc (a
kinase-defective mutant of mouse ActRIIB with Lys217 to Arg217
substitution), and pCS2-Cripto/Flag have been described elsewhere
(Yeo and Whitman 2001; Cheng et al. 2003).
Embryo microinjection. Plasmids were linearized and sense strand-
capped mRNA was synthesized using the mMESSAGE mMACHINE
system (Ambion, Austin, Texas, United States). Zebraﬁsh embryos
were dechorinated by pronase treatment and injected between the
one- and four-cell stage. Xenopus embryos at the one- to two-cell stage
were used for injections into the animal pole.
Phenotypic analysis. Zebraﬁsh embryos at 24 h were mounted in
2% methylcellulose and photographed using a Zeiss (Oberkochen,
Germany) M2Bio dissecting microscope. In situ hybrization was
Figure 9. Model for EGF-CFC, Activin
Receptors, Lefty, and TGFb Interactions
(A) In the absence of ligands, the EGF-
CFC coreceptor (solid pink) is constitu-
tively bound to the type I receptor Alk4
(solid green).
(B) Nodal (solid blue) binds to receptor
complexes consisting of EGF-CFC/Alk4
and ActRIIB (solid green).
(C) Lefty (solid yellow) sequesters the
EGF-CFC coreceptor, thereby prevent-
ing Nodal binding to the receptor com-
plexes.
(D) Subtle sequence differences deter-
mine the interaction with the EGF-CFC
coreceptor and the Lefty inhibitor.
Nodal and Vg1/GDF1 (solid blue) require
the EGF-CFC coreceptor for signaling
through ActRIIB and Alk4, while Activin
(solid red) does not. Sqt
ActbB[loopb8] and
Vg1
ActbB[loopb8] (solid blue with red strip)
containing the loop-b8r e g i o no f
ActivinbB can bind to ActRIIB and
Alk4 without the EGF-CFC coreceptor and therefore cannot be blocked by Lefty. Act
Sqt[Finger1-loopb8] (solid red with two blue strips) requires
the coreceptor for receptor complex binding and can be inhibited by Lefty.
DOI: 10.1371/journal.pbio.0020030.g009
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probes to gsc and ntl (Stachel et al. 1993; Schulte-Merker et al. 1994).
Luciferase reporter assay. Luciferase assays were performed with
three to six samples and ﬁve embryos in each sample. Results are
representative of three independent experiments. The injection
mixtures were equalized with respect to total mRNA amount with
LacZ mRNA. The A3-luc reporter DNA construct (25 pg) (Chen et al.
1996) was also coinjected. Whole zebraﬁsh embryos were harvested at
shield stage. Luciferase activity was analyzed using the Luciferase
Reporter Assay system (Promega, Madison, Wisconsin, United States)
according to the manufacturer’s instruction in a Lumat LB9501
(Berthold Technologies, Bad Wildbad, Germany). Owing to the
technical aspects of microinjections, in rare circumstances, a single
outlier was statistically removed from a population using Grubbs’
test/extreme studentized deviate method. Inclusion of outliers into
the populations does not change the statistical signiﬁcance of the p
values; that is, p remains ,0.05, where indicated.
Coimmunoprecipitation analysis. Xenopus embryos were harvested
at stage 10. For chemical cross-linking of proteins, animal halves were
incubated in PBS with 10 mM 3,39-dithiobis(sulfo-succinimidyl
propionate) (DTSSP) (Pierce Biotechnology, Rockford, Illinois,
United States) and incubated for 2 h on ice. Coimmunoprecipitation
was performed as described previously (Yeo and Whitman 2001).
Puriﬁed processed mouse Lefty1, soluble mouse Cripto, and mouse
VEGF-D proteins were obtained from R&D Systems (Minneapolis,
Minnesota, United States). Activity assays were performed by R&D
Systems. The proteins were incubated in PBS with 1 mM DTSSP for 1
h on ice. Coimmunoprecipitation was performed as described
previously (Yeo and Whitman 2001). Samples were treated with 100
mM DTT to cleave DTSSP prior to SDS-PAGE analysis. The following
antibodies were used for immunoprecipitation and Western blot
analysis: anti-Flag mouse monoclonal antibody (clone M2; Sigma, St.
Louis, Missouri, United States), anti-HA mouse monoclonal antibody
(clone 16B12; Covance, Princeton, New Jersey, United States), anti-
HA rabbit polyclonal antibody (Y-11; Santa Cruz Biotechnology,
Santa Cruz, California, United States), anti-c-Myc rabbit polyclonal
antibody (A-14; Santa Cruz Biotechnology), anti-c-Myc mouse
monoclonal antibody (clone Ab-1; Oncogene Science, Tarrytown,
New York, United States), anti-His mouse monoclonal antibody
(clone 6-His; Covance), anti-mLefty1 goat polyclonal antibody (R&D
Systems), and anti-Glu mouse monoclonal antibody (clone Glu-Glu;
Covance). Proteins were visualized using the Super Signal West Pico/




Nucleotide) accession numbers for the sequences discussed in this
paper are ActivinbA (Q9W6I6), ActivinbB (Q91350), human ActRIIB
(P08476), mouse ActRIIB (P27040), rat ActRIIB (P38445), Alk4
(Z22536), BMP7 (P23359), Cripto (P51865), Cryptic (P97766), cyclops
(P87358), GDF1 (P20863), goosecoid (P53544), Lefty1 (Q9W6I6), Lefty2
(P57785), mLefty1 (Q64280), Nodal (P43021), no tail (Q07998), one-eyed
pinhead (O57516), Pitx2 (P97474), squint (O13144), VEGF-D (P97946),
and Vg1 (P09534).
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